https://www.selleckchem.com/products/ca-170.html
This review presents the authors' institutional experience with the preparation and delivery of outpatient CD19-directed CAR-T cell therapy. Information on subclinical astrocyte damage can provide further insight into neuromyelitis optica spectrum disorder (NMOSD) pathophysiology and disease-monitoring strategies. To investigate whether astrocyte and neuroaxonal damage occurs during interattack periods in individuals with NMOSD through longitudinal measurement of serum glial fibrillary acidic protein (sGFAP) and neurofilament light chain
Like
Comment
Share
